| Registered Number:14578273 |
For the year ended 31 January 2025
England and Wales
Unaudited Financial Statements
For the year ended 31 January 2025
JEMIMAPHARMA LIMITED
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
JEMIMAPHARMA LIMITED
Statement of Financial Position
2024
2025
| Property, plant and equipment |
14,684
14,219
2
14,684
14,219
| Trade and other receivables |
6,000
23,677
3
19,654
| Cash and cash equivalents |
22,620
46,297
25,654
| Trade and other payables: amounts falling due within one |
| year |
(31,755)
(35,338)
4
(6,101)
10,959
Net current assets
| Total assets less current liabilities |
25,643
8,118
25,643
Net assets
8,118
8,118
100
17,525
8,018
25,643
8,118
Shareholders' funds
| For the year ended 31 January 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006 |
| The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| HEENA JEMIMA CHOWDRY Director |
| These financial statements were approved and authorised for issue by the Board on 30 October 2025 and were signed by: |
| The notes form part of these financial statements |
1 of 3
For the year ended 31 January 2025
JEMIMAPHARMA LIMITED
Notes to the Financial Statements
Statutory Information
| JEMIMAPHARMA LIMITED is a private limited company, limited by shares, domiciled in England and Wales, |
| registration number 14578273. |
THE RECTORY CHURCH LANE
NORTH OCKENDON
UPMINSTER
ESSEX
RM14 3QH
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| 2. Property, plant and equipment |
16,728
689
17,417
| Provision for depreciation and impairment |
2,509
Charge for year
224
2,733
14,684
14,219
| 3. Trade and other receivables |
2024
2025
23,677
6,000
2 of 3
For the year ended 31 January 2025
JEMIMAPHARMA LIMITED
Notes to the Financial Statements Continued
| 4. Trade and other payables: amounts falling due within one year |
2024
2025
| Taxation and social security |
8,227
2,594
27,111
29,161
35,338
31,755
| 5. Average number of persons employed |
During the year the average number of employees was 2 (2024 : 2)
3 of 3